4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-26-001491
Options or other derivatives
- Chief Technology Officer acquired 9,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Faulkner Eric · Chief Technology Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-02 | Grant or award : show line 1 in the form Restricted Stock Units | +9,500 | 9,500 | D |
Loading xslF345X05/ownership.xml…